Paraganglioma, Extra-Adrenal - 25 Studies Found
Completed |
: RAD001 in Pheochromocytoma or Nonfunctioning Carcinoid :
|
Completed |
: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors :
|
Withdrawn |
: Phase I Trial of Vandetanib Combined With 131I-mIBG to Treat Patients With Advanced Phaeochromocytoma and Paraganglioma :
: 2013-09-10 :
|
Recruiting |
: Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions :
|
Recruiting |
: Familial Investigations of Childhood Cancer Predisposition :
|
Not yet recruiting |
: Lenvatinib in Treating Patients With Metastatic or Advanced Pheochromocytoma or Paraganglioma That Cannot Be Removed by Surgery :
|
Available |
: Expanded Access Program of Ultratrace Iobenguane I131 for Malignant Relapsed/Refractory Pheochromocytoma/Paraganglioma :
: 2016-11-08 : Drug: Ultratrace Iobenguane I131 Subjects will receive a dosimetry dose of AZEDRA and will undergo 3 who |
Recruiting |
: PEN-221 in Somatostatin Receptor 2 Expressing Advanced Cancers Including Neuroendocrine and Small Cell Lung Cancers :
|
Recruiting |
: Nivolumab and Ipilimumab in Treating Patients With Rare Tumors :
|